Pseudomonas Aeruginosa vs Legionella: Why Augmented Care Units Need a Different Response

Dupal UK — Compliance Team

2 hours ago

4 min read

Blue title slide reading Pseudomonas vs Legionella, with Regulation & Compliance, subtitle, and Dupal UK Infection Control labels

Legionella gets most of the attention in water safety conversations, for good reason — it's the risk named in ACOP L8's title. But in the highest-risk clinical areas of a hospital, Pseudomonas aeruginosa is often the more immediate problem, and it doesn't respond to the same controls. Treating the two as interchangeable is one of the more consequential mistakes an estates or infection control team can make.

What counts as “augmented care”

HTM 04-01's Addendum on Pseudomonas aeruginosa defines augmented care as units treating patients in three groups:

Severely immunosuppressed patients — transplant recipients and others on intensive immunosuppressive therapy
Organ-support patients — critical care, renal and respiratory units, including cystic fibrosis services
Patients with extensive skin breaches requiring water contact — burns units, principally

If any part of your site treats patients in these groups, the standard Legionella-focused water safety scheme isn't the whole answer.

Why the same controls don't work for both

Legionella risk is generally traced to the wider distribution system — tanks, pipe runs, and temperature regimes across the building. The standard controls (keeping cold water cold, hot water hot, and eliminating dead-legs) are aimed at that system-wide picture.

Pseudomonas aeruginosa behaves differently. HTM 04-01's guidance is direct about this: its origin is less certain, and it tends to establish within the last two metres of pipework before the outlet — inside the tap or shower fitting itself, often in biofilm on components like flow straighteners, rather than distributed through the system. A building can have textbook Legionella control and still have a live Pseudomonas problem at individual outlets, because the risk sits somewhere the system-wide controls don't reach.

The outlet features that matter most

The addendum names specific design features that increase risk at the outlet:

Complex sensor-operated taps, which show greater colonisation than simple manual fittings
Flow straighteners, whose high surface-area-to-volume ratio gives biofilm more to establish on
Dead-legs and blind ends within the fitting or its immediate pipework
Infrequently used outlets, where stagnation between uses lets biofilm build undisturbed

Thermostatic mixing valves matter here too, but the detail matters: a TMV positioned upstream of a separate manual mixing tap can create its own cold-water dead-leg, while an integral TMV — built into the tap or shower body itself — draws fresh cold water with every use and is the preferred design.

What the guidance actually recommends

Prefer integral thermostatically-controlled outlets over remote TMVs feeding separate mixing taps
Remove or avoid flow straighteners on outlets in augmented care areas where possible
Flush infrequently used outlets daily for at least a minute, and document that it happened
Choose simple, removable, easily disinfected outlet fittings over complex designs — this is stated as a specific preference, not just a general principle
Use point-of-use filtration as an interim control where an outlet can't be brought under control immediately
Sample and respond on a defined schedule: no detection, retest at six months; 1–10 cfu/100mL, risk-assess the outlet's use and retest within days; above 10 cfu/100mL, remediate and retest after three days and again at two weeks

What this means for shower heads and hoses specifically

This is one of the few places where the official guidance and good product design point in exactly the same direction. A shower fitting that's simple, has no flow-straightener geometry for biofilm to establish in, and can be quickly removed, inspected and swapped rather than dismantled and cleaned in place, matches what HTM 04-01 Part C asks for directly — not as a marketing claim, but as a description of the outlet design it prefers over complex sensor and aerator assemblies. A colour-coded replacement scheme also gives an infection control team the daily-flush and outlet-history evidence the addendum's monitoring schedule expects to see.

Key takeaways

Augmented care covers severely immunosuppressed, organ-support and extensive-skin-breach patients — check whether any part of your site qualifies
Legionella control is largely a system-wide problem; Pseudomonas aeruginosa is largely an outlet-level one, concentrated in the last two metres of pipework
Complex taps, flow straighteners, dead-legs and infrequently used outlets are the specific risk features named in the guidance
Simple, removable, easily disinfected outlet fittings are the design HTM 04-01 Part C prefers — not just good practice, but the stated recommendation

FAQ

If we're fully ACOP L8 compliant, are we covered for Pseudomonas too?

Not automatically. ACOP L8 and general Legionella control are necessary but not sufficient in augmented care — HTM 04-01 Part C sets out additional, outlet-focused measures on top.

Which parts of a typical hospital count as augmented care?

Critical care, transplant, renal, respiratory (including cystic fibrosis) and burns units are the clearest examples. If you're unsure whether a specific ward qualifies, that's a question for your infection control team and water safety group to resolve explicitly — not assume either way.

How often should outlets in augmented care areas be sampled?

The addendum sets a risk-based schedule: six-monthly for outlets with no detection, down to days for outlets with significant counts. The frequency should be documented per outlet, not applied as a single blanket schedule for the ward.